Development of a Multivariable Improvement Measure for Gout

Naomi Schlesinger; N. Lawrence Edwards; Anthony E. Yeo; Peter E. Lipsky


Arthritis Res Ther. 2020;22(164) 

In This Article


In summary, the GMIM criteria effectively capture a change in disease severity in chronic refractory gout patients treated with pegloticase. It may serve as an evidence-based tool for assessment of therapies used to treat patients with similar baseline disease severity.